DK1605957T3 - Anvendelse af lupin-konglutin til behandling af type II-diabetes - Google Patents

Anvendelse af lupin-konglutin til behandling af type II-diabetes

Info

Publication number
DK1605957T3
DK1605957T3 DK04708771T DK04708771T DK1605957T3 DK 1605957 T3 DK1605957 T3 DK 1605957T3 DK 04708771 T DK04708771 T DK 04708771T DK 04708771 T DK04708771 T DK 04708771T DK 1605957 T3 DK1605957 T3 DK 1605957T3
Authority
DK
Denmark
Prior art keywords
diabetes
treatment
type
conglutin gamma
lupin conglutin
Prior art date
Application number
DK04708771T
Other languages
Danish (da)
English (en)
Inventor
Paolo Morazzoni
Marcello Duranti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK1605957T3 publication Critical patent/DK1605957T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK04708771T 2003-02-11 2004-02-06 Anvendelse af lupin-konglutin til behandling af type II-diabetes DK1605957T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000237A ITMI20030237A1 (it) 2003-02-11 2003-02-11 Uso della conglutina di lupino per il trattamento del
PCT/EP2004/001111 WO2004071521A1 (fr) 2003-02-11 2004-02-06 Utilisation de conglutine de lupin aux fins du traitement du diabete non insulino-dependant

Publications (1)

Publication Number Publication Date
DK1605957T3 true DK1605957T3 (da) 2008-08-11

Family

ID=32866063

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04708771T DK1605957T3 (da) 2003-02-11 2004-02-06 Anvendelse af lupin-konglutin til behandling af type II-diabetes

Country Status (21)

Country Link
US (1) US7323441B2 (fr)
EP (1) EP1605957B1 (fr)
JP (2) JP2006517212A (fr)
KR (2) KR20110033312A (fr)
CN (1) CN1747739B (fr)
AT (1) ATE391510T1 (fr)
AU (1) AU2004212297B2 (fr)
CA (1) CA2515607C (fr)
CY (1) CY1108138T1 (fr)
DE (1) DE602004012984T2 (fr)
DK (1) DK1605957T3 (fr)
ES (1) ES2303937T3 (fr)
HK (1) HK1085927A1 (fr)
IL (1) IL170200A (fr)
IT (1) ITMI20030237A1 (fr)
NO (1) NO333224B1 (fr)
PL (1) PL214193B1 (fr)
PT (1) PT1605957E (fr)
RU (1) RU2339393C2 (fr)
SI (1) SI1605957T1 (fr)
WO (1) WO2004071521A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del
CA2726231A1 (fr) 2008-05-30 2009-12-03 Fondazione Centro San Raffaele Del Monte Tabor Utilisations de conglutine-g
US9724664B2 (en) 2009-03-27 2017-08-08 Bend Research, Inc. Spray-drying process
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
EP2611529B1 (fr) 2010-09-03 2019-01-23 Bend Research, Inc. Procedede de séchage par pulvérisation
WO2012040502A1 (fr) 2010-09-24 2012-03-29 Bend Research, Inc. Procédé et appareil de séchage par pulvérisation à température élevée
WO2012049215A1 (fr) * 2010-10-12 2012-04-19 Consumo Em Verde - Biotecnologia Das Plantas, S.A. Protéine antimicrobienne
WO2016000939A1 (fr) 2014-06-30 2016-01-07 Fraunhofer-Gesellschaft Zur Foerderung Der Angewanden Forschung E.V. Émulsion renfermant une protéine de lupin
EP3212169B1 (fr) 2014-10-31 2021-01-13 Bend Research, Inc. Procédé de formation de domaines actifs dispersés dans une matrice

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU66892A (sh) * 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin
JPH08127538A (ja) * 1994-10-31 1996-05-21 Masakiyo Takahashi 糖尿病治療薬
JPH0967252A (ja) * 1995-09-05 1997-03-11 Zenkoku Royal Jelly Kosei Torihiki Kiyougikai ローヤルゼリーに含まれるトランス−１０−ヒドロキシ−デセン酸を有効成分とするアンジオテンシン転換酵素阻害剤及びインスリン様作用剤
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del

Also Published As

Publication number Publication date
PT1605957E (pt) 2008-06-27
EP1605957B1 (fr) 2008-04-09
CA2515607C (fr) 2013-10-15
JP2006517212A (ja) 2006-07-20
US20060142185A1 (en) 2006-06-29
CY1108138T1 (el) 2014-02-12
HK1085927A1 (en) 2006-09-08
RU2005125411A (ru) 2006-01-27
EP1605957A1 (fr) 2005-12-21
JP2012153715A (ja) 2012-08-16
JP5504301B2 (ja) 2014-05-28
US7323441B2 (en) 2008-01-29
ATE391510T1 (de) 2008-04-15
CN1747739B (zh) 2013-04-17
NO20053788L (no) 2005-11-11
PL377578A1 (pl) 2006-02-06
KR20110033312A (ko) 2011-03-30
PL214193B1 (pl) 2013-06-28
ITMI20030237A1 (it) 2004-08-12
NO333224B1 (no) 2013-04-15
RU2339393C2 (ru) 2008-11-27
KR101084434B1 (ko) 2011-11-21
DE602004012984T2 (de) 2009-06-04
WO2004071521A1 (fr) 2004-08-26
CA2515607A1 (fr) 2004-08-26
AU2004212297A1 (en) 2004-08-26
IL170200A (en) 2010-05-31
KR20050106415A (ko) 2005-11-09
SI1605957T1 (sl) 2008-08-31
ES2303937T3 (es) 2008-09-01
AU2004212297B2 (en) 2009-09-10
NO20053788D0 (no) 2005-08-10
CN1747739A (zh) 2006-03-15
DE602004012984D1 (de) 2008-05-21

Similar Documents

Publication Publication Date Title
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
MX2008004734A (es) Composicion rica en leucina.
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
PL1898724T3 (pl) Preparat odżywczy dla niemowląt z hydrolizowanymi białkami
BR0107535A (pt) Uso de carotenóides e forma de dosagem unitária destes
BR0308799A (pt) co-glóbulos de dha e alecrim e método de uso
MX2010006195A (es) Composicion nutricional enterica liquida con un volumen de proteina especifico bajo.
GEP20063818B (en) Orodispersible pharmaceutical composition comprising agomelatine
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
WO2005082927A3 (fr) Peptides utilises contre l'hypertension
IL172916A0 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance
IL167250A (en) Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
AU2003207417A1 (en) Use of tryptophan rich peptides
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
TW200513197A (en) Amino acid supplementation for a healthy microbiota ecosystem
BRPI0410761A (pt) uso de leucina, e, composição para administração entérica a pacientes
AR045745A1 (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2
WO2002089741A3 (fr) Compositions et methodes permettant d'ameliorer l'administration de medicament
MY184130A (en) Peptidic growth hormone secretagogues analog compounds and preparations thereof
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases
PT1581239E (pt) Utilização precoce de um extracto de folhas de videira vermelha
WO2006010127A3 (fr) Composes therapeutiques et traitements
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse